Scientists Challenge DEA’s Proposed Psychedelic Scheduling

Early-career scientists from Students for Sensible Drug Policy are challenging the DEA’s proposed scheduling of psychedelic compounds, which they say could criminalize research and jeopardize an FDA breakthrough therapy for postpartum depression.